Kenneth T. Takeoka

Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics.

Brian Y Feng, Lisha Wang, Mei Geng, 2017, ACS infectious diseases.

Interplay of Klebsiella pneumoniae fabZ and lpxC Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane Homeostasis

Lisha Wang, C. Dean, A. Ruzin, 2018, mSphere.

Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae

P. Skewes-Cox, C. Dean, R. Colvin, 2018, Antimicrobial Agents and Chemotherapy.

Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606

C. Dean, D. Richie, Jun-Rong Wei, 2016, PloS one.

LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates

C. Dean, D. Richie, Jun-Rong Wei, 2017, mSphere.

Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens

C. Dean, Angela L. Woods, Jun-Rong Wei, 2017, Antimicrobial Agents and Chemotherapy.